NO20025590L - Fenylglycin-derivater - Google Patents
Fenylglycin-derivaterInfo
- Publication number
- NO20025590L NO20025590L NO20025590A NO20025590A NO20025590L NO 20025590 L NO20025590 L NO 20025590L NO 20025590 A NO20025590 A NO 20025590A NO 20025590 A NO20025590 A NO 20025590A NO 20025590 L NO20025590 L NO 20025590L
- Authority
- NO
- Norway
- Prior art keywords
- phenylglycine derivatives
- phenylglycine
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/32—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D317/34—Oxygen atoms
- C07D317/36—Alkylene carbonates; Substituted alkylene carbonates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
- C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
- C07C257/18—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/12—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines
- C07C259/18—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines having carbon atoms of hydroxamidine groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/20—Oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00110881 | 2000-05-23 | ||
| PCT/EP2001/005633 WO2001090051A1 (fr) | 2000-05-23 | 2001-05-17 | Derives de phenylglycine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20025590D0 NO20025590D0 (no) | 2002-11-21 |
| NO20025590L true NO20025590L (no) | 2002-11-21 |
Family
ID=8168800
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20025590A NO20025590L (no) | 2000-05-23 | 2002-11-21 | Fenylglycin-derivater |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US6548694B2 (fr) |
| EP (1) | EP1289939A1 (fr) |
| JP (1) | JP3842132B2 (fr) |
| KR (1) | KR100569517B1 (fr) |
| CN (1) | CN1305839C (fr) |
| AR (1) | AR028596A1 (fr) |
| AU (2) | AU8177401A (fr) |
| BR (1) | BR0110998A (fr) |
| CA (1) | CA2408602C (fr) |
| EC (1) | ECSP024360A (fr) |
| HU (1) | HUP0302073A2 (fr) |
| IL (1) | IL152581A0 (fr) |
| MA (1) | MA26905A1 (fr) |
| MX (1) | MXPA02011466A (fr) |
| NO (1) | NO20025590L (fr) |
| NZ (1) | NZ522412A (fr) |
| PE (1) | PE20011314A1 (fr) |
| PL (1) | PL361355A1 (fr) |
| RU (1) | RU2268257C2 (fr) |
| UY (1) | UY26721A1 (fr) |
| WO (1) | WO2001090051A1 (fr) |
| YU (1) | YU83602A (fr) |
| ZA (1) | ZA200208899B (fr) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100473966B1 (ko) * | 1998-12-14 | 2005-03-08 | 에프. 호프만-라 로슈 아게 | 페닐글리신 유도체 |
| DE10300049A1 (de) * | 2003-01-03 | 2004-07-15 | Morphochem AG Aktiengesellschaft für kombinatorische Chemie | Neue Verbindungen, die Faktor VIIa inhibieren |
| US6642386B2 (en) | 2002-02-06 | 2003-11-04 | Hoffmann-La Roche Inc. | N-(4-carbamimidoyl-phenyl)-glycine derivatives |
| GB0211931D0 (en) * | 2002-05-23 | 2002-07-03 | Univ Liverpool | Methods & device utilizing adsorption of molecules at a surface or interface |
| TW200410921A (en) * | 2002-11-25 | 2004-07-01 | Hoffmann La Roche | Mandelic acid derivatives |
| US7144895B2 (en) | 2003-02-11 | 2006-12-05 | Bristol-Myers Squibb Co. | Benzene acetamide compounds useful as serine protease inhibitors |
| US7122559B2 (en) | 2003-02-11 | 2006-10-17 | Bristol-Myers Squibb Company | Phenylglycine derivatives useful as serine protease inhibitors |
| DE10306202A1 (de) * | 2003-02-13 | 2004-08-26 | Grünenthal GmbH | Arzneimittel enthaltend substituierte 2-Aryl-Aminoessigsäure-Verbindungen und/oder substituierte 2-Heteroaryl-Aminoessigsäure-Verbindungen |
| US7917130B1 (en) | 2003-03-21 | 2011-03-29 | Stratosaudio, Inc. | Broadcast response method and system |
| US7776804B2 (en) * | 2005-03-16 | 2010-08-17 | The Lubrizol Corporation | Viscosity improver compositions providing improved low temperature characteristics to lubricating oil |
| US7056932B2 (en) * | 2003-12-19 | 2006-06-06 | Hoffman-La Roche Inc. | Heterocyclyl substituted 1-alkoxy acetic acid amides |
| US20080132507A1 (en) * | 2004-10-13 | 2008-06-05 | Eisai R&D Management Co., Ltd. | Hydrazide Derivatives |
| CA2584485C (fr) * | 2004-10-20 | 2013-12-31 | Resverlogix Corp. | Stilbenes et chalcones utilises pour la prevention et le traitement de maladies cardio-vasculaires |
| DE602006016566D1 (de) | 2005-01-10 | 2010-10-14 | Bristol Myers Squibb Co | Als antikoagulanzien verwendbare phenylglycinamid-derivate |
| ES2337831T3 (es) * | 2005-06-24 | 2010-04-29 | Bristol-Myers Squibb Company | Derivados de fenilglicinamida y piridilclicinamida utiles como agentes anticoagulantes. |
| WO2007103996A1 (fr) * | 2006-03-09 | 2007-09-13 | Bristol-Myers Squibb Company | Inhibiteurs du facteur viia de type 2-(aryloxy)acétamide pouvant être employés en tant qu'anticoagulants |
| MX2008012031A (es) * | 2006-03-24 | 2008-10-02 | Eisai R&D Man Co Ltd | Derivado de triazolona. |
| US7855194B2 (en) | 2006-03-27 | 2010-12-21 | Hoffmann-La Roche Inc. | Pyrimidine, quinazoline, pteridine and triazine derivatives |
| DK2118074T3 (en) | 2007-02-01 | 2014-03-10 | Resverlogix Corp | Compounds for the prevention and treatment of cardiovascular diseases |
| EP1967522A1 (fr) * | 2007-03-07 | 2008-09-10 | Novo Nordisk A/S | Nouveaux inhibiteurs de coagulation sanguine |
| WO2009038157A1 (fr) * | 2007-09-21 | 2009-03-26 | Eisai R & D Management Co., Ltd. | Dérivé de 2,3-dihydroiminoisoindole |
| US8631448B2 (en) | 2007-12-14 | 2014-01-14 | Stratosaudio, Inc. | Systems and methods for scheduling interactive media and events |
| ES2532402T3 (es) * | 2008-06-26 | 2015-03-26 | Resverlogix Corporation | Métodos de preparación de derivados de quinazolinona |
| NZ594332A (en) | 2009-01-08 | 2013-09-27 | Resverlogix Corp | Compounds for the prevention and treatment of cardiovascular disease |
| NZ755378A (en) | 2009-03-18 | 2022-07-29 | Resverlogix Corp | Novel quinazolinones and related compounds for use as anti-inflammatory agents |
| US9757368B2 (en) | 2009-04-22 | 2017-09-12 | Resverlogix Corp. | Anti-inflammatory agents |
| CN102887836B (zh) * | 2011-07-18 | 2014-03-26 | 西南大学 | L-苯甘氨酸衍生物及其应用 |
| PT2773354T (pt) | 2011-11-01 | 2019-07-17 | Resverlogix Corp | Formulações orais de libertação imediata para quinazolinonas substituídas |
| GB201118876D0 (en) * | 2011-11-01 | 2011-12-14 | Astex Therapeutics Ltd | Pharmaceutical compounds |
| US9073878B2 (en) | 2012-11-21 | 2015-07-07 | Zenith Epigenetics Corp. | Cyclic amines as bromodomain inhibitors |
| US9765039B2 (en) | 2012-11-21 | 2017-09-19 | Zenith Epigenetics Ltd. | Biaryl derivatives as bromodomain inhibitors |
| CA2895905A1 (fr) | 2012-12-21 | 2014-06-26 | Zenith Epigenetics Corp. | Nouveaux composes heterocycliques en tant qu'inhibiteurs de bromodomaine |
| CA2977308A1 (fr) | 2015-03-13 | 2016-09-22 | Resverlogix Corp. | Compositions et procedes therapeutiques pour le traitement de maladies associees au complement |
| CN111072562B (zh) * | 2019-11-07 | 2021-12-07 | 中山大学 | 一种四氢异喹啉衍生物及其制备方法和应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2201396T3 (es) * | 1997-12-04 | 2004-03-16 | F. Hoffmann-La Roche Ag | Derivados de la n - (4-carbamimido-fenil) -glicinamida. |
| US6358960B1 (en) | 1998-02-17 | 2002-03-19 | Ono Pharmaceutical Co., Ltd. | Amidino derivatives and drugs containing the same as the active ingredient |
| KR100473966B1 (ko) * | 1998-12-14 | 2005-03-08 | 에프. 호프만-라 로슈 아게 | 페닐글리신 유도체 |
-
2001
- 2001-05-16 US US09/858,535 patent/US6548694B2/en not_active Expired - Fee Related
- 2001-05-17 IL IL15258101A patent/IL152581A0/xx unknown
- 2001-05-17 AU AU8177401A patent/AU8177401A/xx active Pending
- 2001-05-17 MX MXPA02011466A patent/MXPA02011466A/es active IP Right Grant
- 2001-05-17 JP JP2001586241A patent/JP3842132B2/ja not_active Expired - Fee Related
- 2001-05-17 RU RU2002133215/04A patent/RU2268257C2/ru active
- 2001-05-17 NZ NZ522412A patent/NZ522412A/en unknown
- 2001-05-17 WO PCT/EP2001/005633 patent/WO2001090051A1/fr active IP Right Grant
- 2001-05-17 BR BR0110998-7A patent/BR0110998A/pt not_active IP Right Cessation
- 2001-05-17 CA CA002408602A patent/CA2408602C/fr not_active Expired - Fee Related
- 2001-05-17 CN CNB018099297A patent/CN1305839C/zh not_active Expired - Fee Related
- 2001-05-17 KR KR1020027015798A patent/KR100569517B1/ko not_active IP Right Cessation
- 2001-05-17 PL PL36135501A patent/PL361355A1/xx not_active Application Discontinuation
- 2001-05-17 AU AU2001281774A patent/AU2001281774B2/en not_active Ceased
- 2001-05-17 EP EP01960221A patent/EP1289939A1/fr not_active Withdrawn
- 2001-05-17 PE PE2001000442A patent/PE20011314A1/es not_active Application Discontinuation
- 2001-05-17 HU HU0302073A patent/HUP0302073A2/hu unknown
- 2001-05-17 YU YU83602A patent/YU83602A/sh unknown
- 2001-05-21 AR ARP010102385A patent/AR028596A1/es not_active Application Discontinuation
- 2001-05-22 UY UY26721A patent/UY26721A1/es not_active Application Discontinuation
-
2002
- 2002-11-01 ZA ZA200208899A patent/ZA200208899B/en unknown
- 2002-11-21 NO NO20025590A patent/NO20025590L/no not_active Application Discontinuation
- 2002-11-22 EC EC2002004360A patent/ECSP024360A/es unknown
- 2002-11-22 MA MA26921A patent/MA26905A1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| UY26721A1 (es) | 2001-12-28 |
| AU2001281774B2 (en) | 2005-03-10 |
| US20020004608A1 (en) | 2002-01-10 |
| JP3842132B2 (ja) | 2006-11-08 |
| RU2268257C2 (ru) | 2006-01-20 |
| CN1305839C (zh) | 2007-03-21 |
| YU83602A (sh) | 2006-05-25 |
| ZA200208899B (en) | 2004-02-19 |
| US6548694B2 (en) | 2003-04-15 |
| MA26905A1 (fr) | 2004-12-20 |
| ECSP024360A (es) | 2003-03-31 |
| PL361355A1 (en) | 2004-10-04 |
| NZ522412A (en) | 2004-05-28 |
| HUP0302073A2 (hu) | 2003-09-29 |
| CA2408602A1 (fr) | 2001-11-29 |
| JP2003534311A (ja) | 2003-11-18 |
| CA2408602C (fr) | 2008-01-08 |
| AR028596A1 (es) | 2003-05-14 |
| MXPA02011466A (es) | 2003-04-25 |
| KR100569517B1 (ko) | 2006-04-07 |
| NO20025590D0 (no) | 2002-11-21 |
| CN1430599A (zh) | 2003-07-16 |
| EP1289939A1 (fr) | 2003-03-12 |
| WO2001090051A1 (fr) | 2001-11-29 |
| PE20011314A1 (es) | 2002-01-04 |
| KR20030007678A (ko) | 2003-01-23 |
| AU8177401A (en) | 2001-12-03 |
| IL152581A0 (en) | 2003-05-29 |
| BR0110998A (pt) | 2003-04-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20025590L (no) | Fenylglycin-derivater | |
| DK1292604T3 (da) | 2-Aminocarbonyl-9H-purinderivater | |
| ATE540013T1 (de) | Naphthalinderivate | |
| ATE288437T1 (de) | Tetrahydro-heterocycloazepinyl-pyrimidin-deriva e | |
| ATE274491T1 (de) | Phenylglycin-derivate | |
| EE200300071A (et) | Kinasoliini derivaadid | |
| ATE298332T1 (de) | Decahydro-isochinolinderivate | |
| DK1280809T3 (da) | Antitumorecteinascidinderivater | |
| NO20023770L (no) | Indol-3-ylderivater | |
| NO20030276L (no) | Fremgangsmåte | |
| DK1368299T3 (da) | Substituerede C-cyclohexylmethylaminderivater | |
| AR028602A1 (es) | Derivados de pirrol | |
| AR028282A1 (es) | Derivados de aminofenil pirimidona | |
| DK1322593T3 (da) | O-substituerede-6-methyl-tramadol-derivater | |
| ATE282021T1 (de) | Substituierte aminomethyl-phenyl- cyclohexanderivate | |
| PT1351959E (pt) | Novos derivados de pleuromutilina | |
| ATE280752T1 (de) | Aminomethyl-phenyl-cyclohexanonderivate | |
| DE50112454D1 (de) | Substituierte 5-amino-1-penten-3-ol-derivate | |
| ATE374776T1 (de) | Pyrrolotriazolopyrimidinonderivate | |
| NO20024393D0 (no) | 2-fenylpyran-4-on-derivater | |
| DK1246793T3 (da) | Substituerede aminomethyl-phenyl-cyclohexanderivater | |
| DOP2000000093A (es) | Derivados de benzamina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |